Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05652088 · ClinicalTrials.gov registry record · NA
The Role of the Gastrointestinal-associated Lymphoid Tissue in the Cure of HIV Infection
A NA study of HIV Infection, sponsored by Icahn School of Medicine at Mount Sinai.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT05652088: Recruiting NA study of HIV Infection, sponsored by Icahn School of Medicine at Mount Sinai.
NCT05652088 is a NA study of HIV Infection that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 10 participants, below the 243-participant average among 73 other HIV Infection trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05652088, a NA study of HIV Infection, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to understand the effects of HIV cure strategies on the virus and immune cells that reside within the gastrointestinal tract. Subjects receiving therapies with the potential for HIV cure will undergo a colonoscopy to obtain gastrointestinal tissue for research assays. This study will test whether receiving these therapies will induce changes in the immune cells in the gastrointestinal tract and reduce the tissue-associated HIV viral levels.
Primary Outcome
Change in HIV in tissue-associated HIV RNA viral load at the end of the study at month one compared to baseline
Conditions Studied
Interventions
- PROCEDURE Colonoscopy
Study Locations (1)
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2023-06-30 |
| Est. Completion | 2026-06 |
| Phase | NA |
What NCT05652088 shows while recruiting
NCT05652088 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 243-participant average among 73 other HIV Infection trials with a reported enrollment target (96% lower).
The record links to 1 condition, with HIV Infection appearing as the primary indexed condition, and to 1 intervention - of which Colonoscopy is the first listed.
NCT05652088 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05652088 about?
NCT05652088 is a clinical study titled "The Role of the Gastrointestinal-associated Lymphoid Tissue in the Cure of HIV Infection". The objective of this study is to understand the effects of HIV cure strategies on the virus and immune cells that reside within the gastrointestinal tract. Subjects receiving therapies with the potential for HIV cure will undergo a colonoscopy to obtain gastrointestinal tissue for research assays. ...
What is the current status of trial NCT05652088?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2023-06-30. Estimated completion is 2026-06.
What conditions does trial NCT05652088 study?
This clinical trial studies the following conditions: HIV Infection.
What interventions are being tested in trial NCT05652088?
The interventions under investigation include: Colonoscopy (PROCEDURE).
Who is sponsoring clinical trial NCT05652088?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05652088 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05652088's enrollment target sits among peer trials
10 70th of 73 higher than 3 of 73 other HIV Infection trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infection trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
HIV+ Deceased Donor Heart Transplant Study for HIV+ Recipients
RECRUITING · NA
-
Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
RECRUITING · NA
-
Suubi-Mhealth: A Mobile Health Intervention to Address Depression Among Youth
RECRUITING · NA
-
Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With Men
ACTIVE NOT RECRUITING · NA
-
Technology-based Training Tool for PHAT Life
COMPLETED · NA
-
Physician Focused Intervention to Improve Adherence With HIV Antiretrovirals
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI